Tuesday, August 3, 2010

Long-Term Follow-Up of DCVax®-Treated Brain Cancer Patients Shows 33% of Patients Reached 4-Year Survival and 27% ... http://www.pharmainfo.net/pharma-industry-news/08/03/2010/long-term-follow-dcvax%C2%AE-treated-brain-cancer-patients-shows-33-patie
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)